-
×èòàòåëü Íåäóã.ÐóÑîîáùåíèå îò cyril1934
Ñèìòîìû îáüÿñíÿþòüñÿ ïî÷òè òî÷íî òàê æå êàê è ïðè èåðñèíèÿõ è ñàëüìîíåëëàõ.
1.Íàëè÷èåì äàíîé èíôåêöèè â ÆÊÒ, ñîîòâ. èíòîêñèêàöèåé, ñèíäðîìîì ìàëüàáñîðáöèè.
2.Íàëè÷åì äàíîãî èíô. àãåíòà â ìî÷åïîëîâîé ñèñ-ìå.
3.Íàëè÷èåì äàíîãî âîçáóäèòåëÿ è ëèìô. ñèñ-ìå.
4.Ïðîäóêöèåé ýíäîòîêñèíà(è äðóãèõ:øèãåëî-ïîäîáíîãî, ýíòåðî è ò.ä.)
5.Óãíåòåíèåì ôàãîöèòîçà
6.Óãíåòåíèåì ïðîäóöèè ãëîáóëèíîâ, îñîáåííî À
7.Óãíåòåíèåå ôóíêöèè ãàìà-èíòåðôåðîíà è êàêèõ-òî(íåïîìíþ) èíòåðëåéêèíîâ.
Ñ óâàæåíèåì,
-
×èòàòåëü Íåäóã.ÐóÑîîáùåíèå îò cyril1934
Ñ óâàæåíèåì,
-
Ñîîáùåíèå îò äàíò85
-
âîò âåðñèÿ îäíîãî àìåðèêàíöà. Ó íåãî íàøëè â êèøå÷íèêå ýòîò Citrobacter - åäèíñòâåííàÿ áîðüáà ñ íèì - ýòî ïî åãî ìíåíèþ ïîëíîñòüþ îòêàçàòüñÿ îò ñàõàðà è êðàõìàëà.
http://www.scdiet.org/7archives/scd1/scd037.html
-
À ó âòîðîãî íàøëè Citrobacter â ìî÷å, åùå E.Coli, íî äèàãíîç áûë - Àìåáèàçèñ. íîâûé âèä ïàòîãåííûõ àìåá.
http://arpa.allenpress.com/arpaonlin...N%3E2.0.CO%3B2
-
È â çàêëþ÷åíèè îíè ïèøóò:
In conclusion, it is important to remember the amebae when formulating differential diagnoses in immunocompromised or chronically ill patients who present with symptoms of sepsis but do not respond to therapy, or in whom a pathogen cannot be found as a cause for invasive lesions.
 çàêëþ÷åíèè, âàæíî ïîìíèòü íàñ÷åò àìåá êîãäà ôîðìóëèðóåòñÿ äèôôåðåíöèàëüíûé äèàãíîç â èììóíîêîìïðîìèçèðîâàííûõ èëè õðîíè÷åñêè áîëüíûõ ïàöèåíòàõ êîòîðûå ïðåçåíòóþòñÿ ñ ñèìïòîìàìè ñåïñèñà íî íå îòâå÷àþò íà òåðàïèþ, èëè ó êîòîðûõ ïàòîãåí íå ìîæåò áûòü íàéäåí êàê ïðè÷èíà íàãíîåíèé.
Òàê ÷òî íàäî ïîìíèòü åùå íàñ÷åò àìåá.
-
À - è ïàöèåíò ñêîí÷àëñÿ ÷åðåç äâà äíÿ ïîñëå ïðèåìà â ãîñïèòàëå. Ýòî âñå - àìåá - óæå íàøëè ïðè âñêðûòèè. Òàì ôîòêè òîæå åñòü, åñëè êîìó èíòåðåñíî.
Òèïà ïîëîñòè â ìîçãó è ëåãêèõ 0,2 -1 ñì â äèàìåòðå.
Àìåáû è ïðîñòåéøèå ïðîäóöèðóþò ìåíüøå öèòîêèíîâ, ïîýòîìó êàê òàêîâîé íåò îñòðîé ðåàêöèè ñåïñèñà è èììóííîé ñèñòåìû. Èõ êîë-âî äîëæíî áûòü â 10000 ðàç áîëüøå ÷åì áàêòåðèé (èíòðàñåëëþëÿðíûõ) ÷òîáû âûçâàòü ïîäîáèå ñåïòè÷åñêîãî øîêà.
Ê òîìó æå òóò ÷èòàë â÷åðà, ÷òî ïðîñòåéøèå â ëàáîðàòîðèÿõ çàðàæåíû ìèêîïëàçìîé, ýòî ÿ íå ñîâñåì ïîíèìàþ - êàêîå òî íîâîå îòêðûòèå.  áîëüøèíñòâå òèïà ëàáîðàòîðèé îäíîêëåòî÷íûå ê òîìó æå åùå çàðàæåíû ìèêîïëàçìîé è ýòî êàê òî âëèÿëî îêàçûâàåòñÿ íà îïûòû, äî íåäàâíåãî ìîìåíòà îá ýòîì íå ïîäîçðåâàëè. Åñòü åùå ëþäè êîòîðûå íà áåñïëîäèå âûðàùèâàþò äåòåé â ïðîáèðêå - òàê 45% íåóäà÷ ïðè òàêèõ ýêñïåðèìåíòàõ áûëî ñâÿçàíî ñ òåì ÷òî íà ñòåíàõ â ãîñïèòàëÿõ òîæå íàõîäèëèñü íåêèå áàêòåðèè è ýìáðèîíû áûëè èìè áóêâàëüíî "ñúåäàëèñü", íî òîæå îá ýòîì íå ïîäîçðåâàëè äî ñèõ ïîð.
-
èíòåðåñíûé ñëó÷àé èäåíòè÷íûé ïåðâîìó.
CASE 1
A 51-year-old female with an 11-year history of irritable bowel syndrome and fatigue had consulted with four medical physicians.
• Traditional medical approach. Medical testing included an upper and lower GI study and colonoscopy. All found negative for any pathologies. Treatment consisted of the prescription hyoscyamine.
Results were poor.
• Functional medical approach. Following an extensive history and review of her medical records, a digestive stool test and an allergy blood test were done. Two bacterial pathogens were found: Pseudomonas aeruginosa and Citrobacter freundii. The medical literature clearly linked these pathogens to diarrhea disease. An allergy test revealed a significant sensitivity to gluten and rice.
The patient was prescribed a natural pharmaceutical that helped eradicate the two bacterial pathogens and was placed on an elimination diet addressing the rice and gluten. After one month, she was symptom-free.
-
Êàæåòñÿ, ðàçîáðàëàñü ñ òàáëèöåé. Ñêîðåå âñåãî, ïðîâîäèëîñü èññëåäîâàíèå àíòèáàêòåðèàëüíîé àêòèâíîñòè ðàçëè÷íûõ ïðåïàðàòîâ ïî îòíîøåíèþ ê öèòðîáàêòåð â çàâèñèìîñòè:
1.îò êîíöåíòðàöèè ïðåïàðàòà
2. îò ÷óâñòâèòåëüíîñòè øòàììà.
Òåìíûå ïîëÿ-çíà÷åíèÿ ëåæàò çà ïðåäåëàìè èññëåäîâàíèé. Æåëòûå ïîëÿ ïðèíàäëåæàò ÷óâñòâèòåëüíûì øòàììàì áàêòåðèé, ñâåòëî-ñåðûå - íåéòðàëüíûì, òåìíî-ñåðûå - óñòîé÷èâûì.
Ïðèìåð: öèïðîôëîêñàöèí- 59% ÷óâñòâèòåëüíûõ øòàììîâ áóäóò ýôôåêòèâíî ïîäàâëÿòüñÿ äàæå ïðè òàêîé íèçêîé êîíöåíòðàöèè ïðåïåðàòà (â ïðîáèðêå), êàê 0, 3. Ïðè âîçðàñòàíèè êîíöåíòðàöèè % óñïåõà ðàñòåò.
À âîò, ê ïðèìåðó, ýôôåêòèâíîñòü Meropenem äîõîäèò äî 100 %, íî ïðè óñëîâèè âûñîêèõ êîíöåíòðàöèé. ×òîáû äîñòè÷ü ïîäîáíûõ êîíöåíòðàöèé â îðãàíèçìå, íóæíî ïðèíèìàòü ñîîòâåòñòâóþùèå äîçû ïðåïàðàòà, êîòîðûå ìîãóò áûòü óæå òîêñè÷íûìè.
Òàê ÷òî îäíîçíà÷íî âîñïîëüçîâàòüñÿ òàáëèöåé íåëüçÿ.
-
Õîòÿ íåò, ïàðäîí, Meropenem, âñå æå íàèáîëåå ýôôåêòèâåí. Äëÿ íåãî ïðè ÌÏÊ 0,06 ïðöåíò óñïåõà óæå äîñòàòî÷íî âûñîê-94.
-
Ñîîáùåíèå îò cyril1934
-
×èòàòåëü Íåäóã.Ðó
Äàæå ðåïòèëèè áîëåþò ýòèì öèòðîáàêòåðîì.
Ïîêîïàëñÿ â ôîòîãðàôèÿõ....îí äàæå âíåøíå ñìàõèâàåò íà ñàëüìîíåëë è êèøå÷íóþ ïàëî÷êó....
âîò âðîäå íåïëõîé ëèñò ññûëîê íà íåãî:
http://www.itis.usda.gov:8080/servle...arch_value=273
Ñ óâàæåíèåì,
-
×èòàòåëü Íåäóã.Ðó
Ñïèñîê âîçìîæíûõ èññëåäîâàíèé....âîò òîëüêî ãäå:
http://www.altey.ru/adddocs/p64d9.html
Ñ óâàæåíèåì,
-
×èòàòåëü Íåäóã.Ðó
ÈÌÕÎ âïîëíå ïîëåçíî:
http://www.npods.ru/upload/1054105955.doc
Ñ óâàæåíèåì,
-
×èòàòåëü Íåäóã.Ðó
Ðóêîâîäñòâî ïî ÎÊÈ îò âîåííûõ:
http://www.infectology.ru/DOC/Ukaz%20OKI.pdf
Ñ óâàæåíèåì,